Interaction Between White Potato Consumption and Meal Timing on Glycemic Response and Appetite in Adults

NCT07230951 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-11-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate the interaction between white potato consumption and meal timing on glycemic response, subjective appetite, and energy intake in adults. The investigators hypothesize that white potatoes will modulate glycemic response, enhance satiety, and mitigate subsequent meal consumption and overall food intake when compared with meals containing low glycemic carbohydrates. Furthermore, they anticipate that the timing of white potato consumption will yield differential effects, with breakfast consumption exerting a more pronounced impact on satiety and subsequent food intake reduction compared to dinner consumption.

Conditions

  • Healthy
  • Adult
  • Appetite
  • Glycemic Response
  • Mealtiming

Interventions

OTHER

Oven-baked Home Fries

Oven-baked Home Fries (241 g; McCain Ltd.). Test treatments matched for calories (284 kcal)

OTHER

Oven-baked White Russet Potato

Oven-baked White Russet Potato (299 g). Test treatments matched for calories (284 kcal)

OTHER

Oven-baked Fries

Oven-baked Fries (201 g; McCain Ltd.). Test treatments matched for calories (284 kcal)

OTHER

Deep Fried, Quick Serve Fries

Deep Fried, Quick Serve Fries (108 g; McCain Ltd.). Test treatments matched for calories (284 kcal)

OTHER

Oven-baked Cauliflower Veggie Tots

Oven-baked Cauliflower Veggie Tots (186 g; Green Giant). Test treatments matched for calories (284 kcal)

OTHER

No Side

No side control (no caloric contribution).

Sponsors & Collaborators

  • Alliance for Potato Research and Education

    collaborator OTHER
  • Toronto Metropolitan University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-30
Primary Completion
2027-10-31
Completion
2027-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07230951 on ClinicalTrials.gov